Delhi's LNJP hospital designated to treat Omicron patients | MENAFN.COM

Thursday, 27 January 2022 06:03 GMT

Delhi's LNJP hospital designated to treat Omicron patients


(MENAFN- IANS) >

New Delhi, Nov 30 (IANS) Delhi government-run Lok Nayak Jai Prakash Hospital has been designated to treat patients testing positive for the new Covid-19 variant Omicron.

The hospital has been asked to earmark wards for isolating and treating such patients.

In an order, the Health Department has directed the hospital not to deny admission to patients infected with the new variant on any ground.

'The Union Health Ministry had Sunday (November 28) issued new guidelines for international travellers for reporting of Omicron, which has been classified as a 'variant of concern' by the World Health Organization (WHO),' the order read.

As per the guidelines, a separate isolation unit has to be set up for the patients indicating the presence of Omicron.

'Accordingly, Lok Nayak Hospital is hereby designated as the dedicated hospital which will treat the patients detected with the new variant of SARS-CoV-2. Lok Nayak Hospital will designate one or more separate wards (as per need) for isolating and treating such patients,' it added further.

The World Health Organisation has said that the overall global risk related to the new Covid Variant of Concern Omicron is assessed as very high. The global health body said that Omicron is a highly divergent variant with a high number of mutations, including 26-32 in the spike, some of which are concerning and may be associated with immune escape potential and higher transmissibility. However, there are still considerable uncertainties, added the global health body.

---IANS

avr/shb/

MENAFN30112021000231011071ID1103275977


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.